You also talked about U.S. investors, the lack of venture capital, trials in the U.S., and that's what I picked up on. Do you find, when you look at trade deals and things like that, that we should be looking more at regulatory harmonization? I'm expecting, for what you're trying to sell, that you have to do these trials in all the countries you're bringing your product into. Would regulatory harmonization help with some of that?
On April 27th, 2015. See this statement in context.